The very acute stroke treatment: Fibrinolysis and after

Clinical and Experimental Hypertension

Volumn 24, Issue 7-8, 2002, Pages 595-602

  Caso, Valeria ^a   Hacke, Werner ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CT scan; Penumbra; Stroke; Thrombolysis; Time window

Indexed keywords

ALTEPLASE;

BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CHRONOLOGY; CLINICAL TRIAL; CONFERENCE PAPER; DIFFUSION WEIGHTED IMAGING; DRUG EFFICACY; EMERGENCY HEALTH SERVICE; FIBRINOLYTIC THERAPY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; STROKE; TISSUE DISTRIBUTION;

BLOOD FLOW VELOCITY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; REPERFUSION; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036814096     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-120015335     Document Type: Conference Paper

References (37)

1. Jones, T.H.; Morawetz, R.B.; Crowell, R.M.; Marcoux, EW.; Fitz-Gibbon, S.J.; DeGirolami, U.; Ojemann, R.G. Thereholds of focal cerebral ischemia in awake monkeys. J. Neurosurg. 1981, 54, 773-782.
2. Touzani, O.; Young, A.R.; Derlon, J.M.; Beaudouin, V.; Marchal, G.; Rioux, P.; Mezenge, E; Baron, J.C.; Mackenzie, E.T. Sequential studies of severely hypometabolic tissue volumes after permanent middle cerebral artery occlusion, a positron emission tomographic investigation in anaesthetised baboons. Stroke 1995, 26, 2112-2119.
3. Raichle, M. The pathophysiology of brain ischemia. Ann. Neurol. 1983, 13, 2-10.
4. Siesjo, B.K. Pathophysiology and treatment of focal cerebral ischemia. J. Neurosurg. 1992, 77, 169-184.
5. Astrup, J.; Symon, L.; Branston, N.M.; Lassen, N.A. Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke 1977, 8, 51-57.
6. Lassen, N.A.; Fieschi, C.; Lenzi, G.L. Ischemic penumbra and neuronal death, comments on the therapeutic window in acute stroke with particular reference in thrombolytic therapy. Cerebrovasc. Dis. 1991, 1 (suppl 1), 32-35.
7. Baron, J.C.; von Kummer, R.; del Zoppo, G.J. Treatment of acute ischemic stroke, challenging the concept of a rigid and universal time window. Stroke 1995, 26, 2219-2221 (Editorial).
8. National Institute of Neurological Disorder and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 1995, 333, 1581-1587.
9. Practise advisory, thrombolytic therapy for acute ischemic stroke, summary statement, report of the quality standard subcommittee of the american academy of neurology. Neurology 1996, 47, 835-839.
10. Adams, H.P. Jr.; Brott, T.G.; Furlan, A.J.; Gomez, C.R.; Grotta, J.; Helgason, C.M.; Kwiatkowski, T.; Lyden, P.D.; Marler, J.R.; Torner, J.; Feinberg, W.; Mayberg, M.; Thies, W. Guidelines for thrombolytic therapy for acute stroke, a supplement to the guidelines for healthcare professionals from a special writing group of the stroke council, American heart association. Stroke 1996, 27, 1711-1718.
11. Hacke, W; Kaste, M.; Fieschi, C.; Toni, D.; Lesaffre, E.; von Kummer, R.; Boysen, G.; Hoxter, G.; Mahagne, M.H.; Hennerici, M. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke, The European Cooperative Acute Stroke Study (ECASS). JAMA 1995, 274, 1017-1025.
12. Hacke, W.; Kaste, M.; Fieschi, C.; von Kummer, R.; Davalos, A.; Meier, D.; Iarrue, V.; Bluhmki, E.; Davis, S.; Donnan, G.; Schneider, D.; Diez-Tejedor, E.; Trouillas, P. Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998, 352, 1245-1251.
13. Clark, W.M.; Wissmann, S.; Albers, G.W.; Jhamandas, J.H.; Madden, K.P.; Halmiton, S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after sympton onset. The ATLANTIS study, a randomized controlled trial. JAMA 1999, 282, 2019-2026.
14. Hacke, W.; Brott, T.; Caplan, L.; Meier, D.; Fieschi, C.; von Kummer, R.; Donnan, G.; Heiss, W.D.; Wahlgreen, N.G.; Spranger, M.; Boysen, G.; Marler, J.R. Thrombolysis in acute ischemic stroke, controlled trials and clinical experience. Neurology 1999, 53 (suppl 4), 3-14.
15. Wardlaw, J.M.; Warlow, C.P.; Cousell C. Systematic review of evidence on fibrinolytic therapy for acute ischemic stroke. Lancet 1997, 350, 607-614.
16. Ford, G.; Freetmantle, N. ECASS-II Intravenous alteplase in acute ischemic stroke (letter). Lancet 1999, 353, 65-68.
17. Tomsick, T.; Brott, T.; Barsan, W.; Broderick, J.; Haley, E.C.; Spilker, J.; Khourgi, J. Prognostic value of hypodense middle cerebral infarct sign and stroke scale before early thrombolytic therapy. AJNR Am. J. Neuroradiol. 1996, 17, 1-7.
18. von Kummer, R. Effects of training in reading CT scan on patients section for ECASSII. Neurology 1998, 51 (suppl 3), 850-852.
19. von Kummer, R.; Aller, K.L.; Holle, R.; Bozzao, L.; Manelfe, S.B.; Bluhmki, E.; Ringleb, P.A.; Meier, D.H.; Hacke, W. Acute stroke, usefulness of early CT findings before thrombolytic therapy. Radiology 1997, 205 (2), 327-333.
20. Bozzao, L.; Angeloni, U.; Bastianello, S.; Fantozzi, L.M.; Pierallini, A.; Fieschi, C. Early angiographic and CT-findings in patients with hemorragic infarction in the distribution of the middle cerebral artery. AJNR Am. J. Neuroradiol. 1991, 12 (6), 1115-1121.
21. von Kummer, R.; Meyding-Lamade, U.; Forsting, M.; Rosin, L.; Rieke, K.; Hacke, W.; Sartor, K. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. Am. J. Neuroradiol. 1994, 15 (1), 9-15.
22. Tong, D.C.; Albert, G.W. Diffusion and perfusion magnetic resonance imaging for the evaluation of the acute stroke, potential use in guiding thrombolytic therapy. Curr. Opin. Neurol. 2000, 13, 45-50.
23. Fisher, M.; Albers, G.W. Application of diffusion-perfusion magnetic resonance in acute ischemic stroke. Neurology 1999, 52, 1750-1756.
24. Fisher, M.; Prichard, J.W.; Warach, S. New magnetic resonance techniques for acute ischemic stroke. JAMA 1995, 274, 908-911.
25. Beauchamp, N.J. Jr.; Ulug, A.M.; Passe, T.J.; van Zijl, P.C. MR diffusion imaging in stroke, review and controversies. Radiographics 1998, 18, 1269-1283.
26. Warach, S.; Dashe, J.F.; Edelman, R.R. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging, a preliminary analysis. J. Cereb. Flow. Metab. 1996, 26, 53-59.
27. Saunders, D.E.; Clifton, A.G.; Brown, M.M. Measurement of cerebral infarct size using MRI predicts prognosis in middle cerebral artery infarction. Stroke 1995, 26, 2272-2276.
28. Tong, D.C.; Yenari, M.A.; Albers, G.W.; O'Brien, M.; Marks, M.P.; Moseley, M.E. Correlation of perfusion and diffusion-weighted MRI with NIHSS score in acute (<6.5 hours) ischemic stroke. Neurology 1996, 50, 864-870.
29. Lovblad, K.O.; Baird, A.E.; Schlaug, G.; Benfield, A.; Siewert, B.; Voetsch, B.; Connor, A.; Burzynski, C.; Edelmann, R.R.; Warach, S. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann. Neurol. 1997, 50, 864-870.
30. Sorensen, A.G.; Tievsky, A.L.; Ostergaard, L.; Weisskoff, R.M.; Rosen, B.R. Contrast Agent in functional MR imaging. J. Magnet. Reson. Imaging 1997, 7, 47-55.
31. Barber, P.A.; Darby, D.G.; Desmond, P.M.; Yang, Q.; Gerraty, R.P.; Jolley, D.; Donnan, G.A. Prediction of stroke outcome with echoplanar perfusion-and-diffusion-weighted MRI. Neurology 1998, 51, 418-426.
32. Barber, P.A.; Davis, S.M.; Darby, D.G.; Desmond, P.M.; Gerraty, R.P.; Yang, Q.; Jolley, D.; Donnan, G.A.; Tress, B.M. Absent of middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra. Neurology 1999, 52, 1125-1132.
33. Rodorf, G.; Koroshetz, W.J.; Copen, W.A.; Cramer, S.C.; Schaefer, P.W.; Budzik, R.F. Regional ischemia and ischemic injury in patients with acute cerebral middle artery as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke 1998, 30, 800-806.
34. Marks, M.P.; Tong, D.C.; Beaulieu, C.; Albers, G.W.; de Crespigny, A.; Moseley, M.E. Evaluation of early reperfusion and i.v rt-PA therapy using diffusion and perfusion-weighted MRI. Neurology 1999, 52, 1792-1798.
35. Jansen, O.; Schellinger, P.; Fiebach, J.; Hacke, W.; Sartor, K. Early recanalisation in acute ischemic stroke saves tissues at risk defined by MRI. Lancet 1999, 353, 2036-2037.
36. Schellinger, P.D.; Jansen, O.; Fiebach, J.B.; Heiland, S.; Steiner, T.; Schwab, S.; Pohlers, O.; Ryssel, H.; Sartor, K.; Hacke, W. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke 2000, 31, 1318-1328.
37. Schellinger, P.D.; Jansen, O.; Fiebach, J.B.; Heiland, S.; Steiner, T.; Schwab, S.; Pohlers, O.; Ryssel, H.; Hacke, W.; Sartor, K. Feasibility and practibility of MR imaging of stroke in manegement of hyperacute cerebral ischemia. ANJR. Am. J. Neuroradiology 2000, 21, 1184-1189.